Medrox

Product NDC
68788-9855
11-digit product format
687889855
Labeler code
68788
Product ID
68788-9855_7ff193c5-1ffb-49b8-b0ff-e4ccd0d9855f
Type
HUMAN OTC DRUG
Nonproprietary name
METHYL SALICYLATE, MENTHOL, CAPSAICIN
Dosage form
OINTMENT
Route
TOPICAL
Labeler
Preferred Pharmaceuticals, Inc
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2012-03-12
Marketing end
0000-00-00
Substance
METHYL SALICYLATE; MENTHOL, UNSPECIFIED FORM; CAPSAICIN
Active strength
20 g/100g; g/100g; g/100g
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct68788-9855DDiscontinued by firm2026-10-15
excluded packagepackage68788-985568788-9855-1DDiscontinued by firm2026-10-15
excluded packagepackage68788-985568788-9855-6DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 39 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage68788-9855-1DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage68788-9855-6DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage68788-9855-1DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage68788-9855-6DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage68788-9855-1DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage68788-9855-6DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage68788-9855-1DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage68788-9855-6DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage68788-9855-1DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage68788-9855-6DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage68788-9855-1DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage68788-9855-6DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage68788-9855-1DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage68788-9855-6DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage68788-9855-1DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage68788-9855-6DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage68788-9855-1DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage68788-9855-6DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage68788-9855-1DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage68788-9855-6DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage68788-9855-1DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage68788-9855-6DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage68788-9855-1DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage68788-9855-6DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage68788-9855-1IInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage68788-9855-6IInactivated by FDA9bebd1f3094a…5416666fcb17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
68788-9855-12020-11-20Medrox (Medroxin)
68788-9855-62020-11-20Medrox (Medroxin)
68788-9855-12020-01-31Medrox (Medroxin)
68788-9855-62020-01-31Medrox (Medroxin)

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CAPSAICINACTIVE INGREDIENTS07O44R1ZMMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
MENTHOLACTIVE INGREDIENTL7T10EIP3AMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
METHYL SALICYLATEACTIVE INGREDIENTLAV5U5022YMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
CAPSAICINACTIVE MOIETYS07O44R1ZMMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
MENTHOLACTIVE MOIETYL7T10EIP3AMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW4MEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1MMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJSMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
PEG-150 DISTEARATEINACTIVE INGREDIENT6F36Q0I0ACMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3MEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
TROLAMINEINACTIVE INGREDIENT9O3K93S3TKMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1
WATERINACTIVE INGREDIENT059QF0KO0RMEDROX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PREFERRED PHARMACEUTICALS, INC]1